WINDTREE THERAPEUTICS INC /DE/ Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for the quarter ending 2024-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for the quarter ending 2024-03-31 was $1.37M.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for the quarter ending 2023-06-30 was $10.79M, a 958.24% increase year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for fiscal 2023 was $10.79M.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for fiscal 2021 was $4.80M, a 76.29% decline from fiscal 2020.
- WINDTREE THERAPEUTICS INC /DE/ stock issued during period, value, new issues for fiscal 2020 was $20.25M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2024-09-30 | $0.00 10-Q · filed 2025-11-19 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-11-19 | |
| 2024-03-31 | $1.37M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $10.79M 10-K · filed 2025-04-15 | |
| 2023-06-30 | $10.79M 10-Q · filed 2024-11-26 | |
| 2022-12-31 | $0.00 10-K · filed 2024-04-16 | |
| 2022-09-30 | $1.53M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.02M 10-Q · filed 2022-11-14 | |
| 2021-12-31 | $4.80M 10-K · filed 2023-03-31 | |
| 2021-06-30 | $1.12M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $20.25M 10-K · filed 2021-03-29 | |
| 2020-06-30 | $20.25M 10-Q · filed 2020-11-16 | |
| 2018-06-30 | $2.59M 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $1.03M 10-K/A · filed 2019-04-23 | |
| 2016-12-31 | $709.00K 10-K · filed 2018-04-17 | |
| 2015-12-31 | $37.63M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |